Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 21, 2006; 12(43): 6992-6997
Published online Nov 21, 2006. doi: 10.3748/wjg.v12.i43.6992
Published online Nov 21, 2006. doi: 10.3748/wjg.v12.i43.6992
Table 3 Detailed clinical data of the patients in whom HCC recurred after LT
| Patient | Group | Time to recur (mo) | Site of recur | Treatment after recurrence | Survival (mo) |
| 1 | TACE + LT | 9.6 | Liver | None | 10.0 |
| 2 | TACE + LT | 3.3 | Liver, bone | TACE | 7.1 |
| 3 | LT | 15.4 | Lymph node | Excision, TACE | 21.0 |
| 4 | TACE + LT | 0.9 | Lung, liver | TACE | 5.7 |
- Citation: Kim DY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC, Shin SW, Choo SW, Do YS, Rhee JC. Milan criteria are useful predictors for favorable outcomes in hepatocellular carcinoma patients undergoing liver transplantation after transarterial chemoembolization. World J Gastroenterol 2006; 12(43): 6992-6997
- URL: https://www.wjgnet.com/1007-9327/full/v12/i43/6992.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i43.6992